HealthVerity Notes adds de-identified, unstructured clinical documentation to expand context and enrich patient journey analysis across life sciences use cases
PHILADELPHIA, June 18, 2025 /PRNewswire/ — HealthVerity, the leader in privacy-protecting technologies and the nation’s largest verified healthcare and consumer data ecosystem, today announced the launch of HealthVerity Notes, a modular, de-identified dataset built from over 2.5 billion unstructured clinical EHR notes that employs novel methodologies to preserve the full note. This approach adds vital context to real-world data strategies across life sciences research, commercial pharma and analytics use cases.
Building on a commitment to verified, research-ready data, HealthVerity Notes introduces a new dimension of patient understanding by unlocking free-text documentation from clinical encounters including insights from physician observations and symptom descriptions to disease progression and therapeutic response. Delivered with modular access and accurately linked by HealthVerity IDs (HVIDs), HealthVerity Notes is now available as an integral part of the nation’s largest data ecosystem. The underlying de-identification technology can also be leveraged by data providers to commercialize a wider range of free-text documents.
“With HealthVerity Notes, we’re turning the unstructured into the actionable,” said Andrew Kress, CEO at HealthVerity. “This launch marks an important new capability in our mission to help life sciences organizations unlock deeper insights from real-world data, while preserving patient privacy and ensuring interoperability across datasets.”
By preserving the full text of the original clinical documentation, HealthVerity Notes supports downstream use of natural language processing (NLP), offering linguistically intact and context-rich documentation that complements structured claims, EHR, and lab data. Whether identifying undiagnosed symptoms, tracing adverse events, or capturing disease trajectory, HealthVerity Notes enables more complete, narrative-driven analytics.
HealthVerity Notes is now available with use cases spanning clinical development, HEOR, pharmacovigilance, commercial analytics and patient journey analysis.
To learn more, visit www.healthverity.com/notes or contact info@healthverity.com.
About HealthVerity
HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making.
HealthVerity contact: info@healthverity.com
SOURCE HealthVerity, Inc.
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…